PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Discovery of new white blood cell reveals target for better vaccine design

2012-07-28
(Press-News.org) Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source – providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.

Publishing in the journal Immunity, the team of researchers from Newcastle University in collaboration with A*STAR's Singapore Immunology Network (SIgN) describe a new human tissue dendritic cell with cross-presenting function.

Dendritic cells (DCs) are a type of white blood cell that orchestrate our body's immune responses to infectious agents such as bacteria and viruses, as well as cancer cells. They are also very important for eliciting the immune response generated by vaccines. DCs kick start an immune response by presenting small fragments of molecules from micro-organisms such as bacteria and viruses, or from vaccines or tumours, called antigens on their surface. This leads to activation of another white blood cell subset called T cells, which specialise in killing cells and are crucial for eliminating cancerous or infected cells. Most cells are only able to present antigens from within themselves, and so will only elicit an immune response if they are infected themselves. Only a specialised subset of DCs is able to generate a response to an external source of antigen, for example bacteria, vaccines and tumours.

The identity of human tissue DCs that are capable of presenting external antigen to activate the cell-killing response by T cells - a process termed 'cross-presentation' - has remained a mystery. Their discovery, as revealed by this research, will help scientists to design better targeted vaccine strategies to treat cancer and infections such as Hepatitis B.

"These are the cells we need to be targeting for anti-cancer vaccines," said Dr Muzlifah Haniffa, a Wellcome Trust Intermediate Fellow and Senior Clinical Lecturer at Newcastle University. "Our discovery offers an accessible, easily targetable system which makes the most of the natural ability of the cell."

The researchers also showed for the first time that dendritic cell subsets are conserved between species and have in effect created a map, facilitating the translation of mouse studies to the human immune system.

"The cross-species map is in effect a Rosetta stone that deciphers the language of mouse into human", explains Matthew Collin, Professor of Haematology from Newcastle University.

In the paper the researchers describe how the cross-presenting DCs were first isolated from surplus plastic surgery skin which was digested to melt the gelatinous collagen to isolate the cells.

This research will have significant impact on the design of vaccines and other targeted immunotherapies.

The Rosetta Stone of our immune system: Mapping Human and Mouse dendritic cells

The Newcastle University team in collaboration with A*STAR's Singapore Immunology Network (SIgN) have for the first time ever aligned the dendritic cell subsets between mouse and humans allowing the accurate translation of mouse studies into the human model for the first time.

The researchers isolated the dendritic cells from human blood and skin and those from mouse blood, lung and liver. Using gene expression analysis, they identified gene signatures for each human dendritic cell subset. Mouse orthologues of these genes were identified and a computational analysis was performed to match subsets across species.

This provides scientists for the first time with an accurate model to compare DCs between species.

Professor Matthew Collin explains: "This is in effect a Rosetta stone that deciphers the language of mouse into human. It can put into context the findings from the extensive literature using mouse models to the human settings".

Dr. Haniffa added: "These gene signatures are available in a public repository accessible for all researchers to benefit from the data. It will allow detailed knowledge of individual human dendritic cell subsets to enable specific targeting of these cells for therapeutic strategy."

###Reference: Human Tissues Contain CD141(hi) Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103(+) Nonlymphoid Dendritic Cells. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, Wasan PS, Wang XN, Malinarich F, Malleret B, Larbi A, Tan P, Zhao H, Poidinger M, Pagan S, Cookson S, Dickinson R, Dimmick I, Jarrett RF, Renia L, Tam J, Song C, Connolly J, Chan JK, Gehring A, Bertoletti A, Collin M, Ginhoux F.Immunity. 2012 Jul 11


ELSE PRESS RELEASES FROM THIS DATE:

Landmark HIV treatment-as-prevention study shows additional health benefits, cost-effectiveness

2012-07-28
WHAT: Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals. The two analyses were presented ...

Study finds novel therapy that may prevent damage to the retina in diabetic eye diseases

2012-07-28
Researchers at the University of Michigan Kellogg Eye Center have identified a compound that could interrupt the chain of events that cause damage to the retina in diabetic retinopathy. The finding is significant because it could lead to a novel therapy that targets two mechanisms at the root of the disease: inflammation and the weakening of the blood barrier that protects the retina. To date, treatments for diabetic retinopathy, the leading cause of blindness among working-age Americans, have been aimed largely at one of those mechanisms. In diabetic retinopathy, ...

Tumor cells' inner workings predict cancer progression

Tumor cells inner workings predict cancer progression
2012-07-28
Using a new assay method to study tumor cells, researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center have found evidence of clonal evolution in chronic lymphocytic leukemia (CLL). The assay method distinguishes features of leukemia cells that indicate whether the disease will be aggressive or slow-moving, a key factor in when and how patients are treated. The findings are published in the July 26, 2012 First Edition online issue of Blood. The progression of CLL is highly variable, dependent upon the rate and ...

NASA sees organizing tropical low pressure area near the Philippines

NASA sees organizing tropical low pressure area near the Philippines
2012-07-28
A low pressure system in the western North Pacific has caught the eye of forecasters and several satellites as it continues to organize. NASA's Terra satellite captured a view of System 93W's clouds as they continue to appear more organized. System 93W appears poised to become tropical storm Saola over the next two days if the organization continues. At 1400 UTC (10 a.m. EDT/U.S.; 10 p.m. Asia/Manila local time) System 93W had maximum sustained winds near 20 knots (23 mph/37 kmh). It was located about 395 nautical miles (454.6 miles/731.5 km) east-southeast of Manila, ...

UCLA researchers discover that fluoxetine -- a.k.a., Prozac -- is effective as an anti-viral

2012-07-28
UCLA researchers have come across an unexpected potential use for fluoxetine – commonly known as Prozac – which shows promise as an antiviral agent. The discovery could provide another tool in treating human enteroviruses that sicken and kill people in the U.S. and around the world. Human enteroviruses are members of a genus containing more than 100 distinct RNA viruses responsible for various life threatening infections, such as poliomyelitis and encephalitis. While immunization has all but eliminated the poliovirus, the archetype for the genus, no antiviral drugs ...

Martian polygons and deep-sea polygons on Earth: More evidence for ancient Martian oceans?

2012-07-28
Boulder, Colorado, USA - Debate over the origin of large-scale polygons (hundreds of meters to kilometers in diameter) on Mars remains active even after several decades of detailed observations. Similarity in geometric patterns on Mars and Earth has long captured the imagination. In this new article from GSA Today, geologists at The University of Texas at Austin examine these large-scale polygons and compare them to similar features on Earth's seafloor, which they believe may have formed via similar processes. Understanding these processes may in turn fuel support for ...

Think you're a comic genius? Maybe you're just overconfident

2012-07-28
TALLAHASSEE, Fla. Knock, knock! Who's there? Cows go. Cows go who? No, cows go moo! OK, OK. So it's not a side-slapper — especially if the teller has zero sense of comic timing. But most likely the person sharing the joke over the water cooler thinks he or she is pretty funny. No matter how badly the joke is told, it will sometimes elicit a few polite laughs. Why? Because social norms make us averse to providing negative feedback, says Joyce Ehrlinger, a Florida State University assistant professor of psychology whose latest laboratory research recreated everyday ...

World Hepatitis Day - EASL calls on the United Nations to join the effort to tackle viral hepatitis

2012-07-28
Geneva, 28th July 2012 – Marking World Hepatitis Day, the European Association for the Study of the Liver (EASL) calls on the different organizations which make up the United Nations systems to take action to fight against Viral Hepatitis (Hepatitis B and C), a potentially fatal infection of the liver which affects 500 million people. Viral hepatitis is the cause of death of over one million people a year and, around the world, one in every 3 people has been exposed to either the Hepatitis B virus or the Hepatitis C virus. Even more worrying, those infected do not know ...

Smart Mobile Solutions Announces Its New Notepad Mobile App - Skinny Note!

2012-07-28
Smart Mobile Solutions is proud to announce it is releasing its newest app for mobile devices - Skinny Note! Skinny Note is an easy to use and fun notepad application for Android devices. It allows users to create text notes, diary notes, check lists, to do lists, reminder lists, and much more, all in a fun and easy-to-use interface. Some of Skinny Note's notable features include: - Customize notes through font size and background color - Filter notes based on color and/or type - Set up notifications for specific notes - Categorize notes based on colors and names - Sort ...

5W Public Relations Named PR Agency of Record For SNAP Infusion

2012-07-28
5W Public Relations a leading NY PR Agency is pleased to announce the addition of SNAP Infusion to its growing roster of clients. 5W Public Relations will execute a comprehensive public relations program designed to increase awareness of the company with the goal of becoming recognized as the category leader. "We are thrilled to be working with SNAP Infusion's line of SUPERCANDY ," said Ronn Torossian, CEO of 5WPR. "Given our extensive experience creating and implementing successful public relations programs for other consumer products, we are confident ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Discovery of new white blood cell reveals target for better vaccine design